Campbell's Sales Decline: Campbell's reported a 3% decrease in net sales to $2.68 billion and a 13% drop in adjusted earnings, leading to a nearly 6% stock decline, despite exceeding Wall Street expectations.
Exxon Mobil's Growth Forecast: Exxon Mobil's stock rose 2.7% after announcing an updated corporate plan projecting $25 billion in earnings growth and $35 billion in cash flow growth from 2024 to 2030.
Staar Surgical's Takeover Bid: Staar Surgical's shares surged over 12% after Alcon increased its takeover bid to $30.75 per share, representing a 30.6% premium from the previous closing price.
Teleflex Divestment Strategy: Teleflex's stock rose more than 9% after announcing the sale of three business units for $2.03 billion, with plans to use the proceeds for stock buybacks and debt reduction.
Wall Street analysts forecast ARES stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARES is 196.55 USD with a low forecast of 175.00 USD and a high forecast of 222.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast ARES stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARES is 196.55 USD with a low forecast of 175.00 USD and a high forecast of 222.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
2 Hold
0 Sell
Strong Buy
Current: 161.520
Low
175.00
Averages
196.55
High
222.00
Current: 161.520
Low
175.00
Averages
196.55
High
222.00
Oppenheimer
Oppenheimer
Outperform
maintain
$190 -> $224
2026-01-20
New
Reason
Oppenheimer
Oppenheimer
Price Target
$190 -> $224
AI Analysis
2026-01-20
New
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on Ares Management to $224 from $190 and keeps an Outperform rating on the shares. The firm adjusted targets in the alternative asset manager group as part of a Q4 preview.
Barclays
Overweight
maintain
$218 -> $222
2026-01-09
Reason
Barclays
Price Target
$218 -> $222
2026-01-09
maintain
Overweight
Reason
Barclays raised the firm's price target on Ares Management to $222 from $218 and keeps an Overweight rating on the shares. The firm adjusted targets in the alternative asset manager group as part of its Q4 outlook. Barclays expect realizations to pick up meaningfully across the board. The market-wide concerns around credit performance are overblown, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ARES
Unlock Now
Wolfe Research
Outperform
maintain
$204 -> $210
2026-01-07
Reason
Wolfe Research
Price Target
$204 -> $210
2026-01-07
maintain
Outperform
Reason
Wolfe Research raised the firm's price target on Ares Management to $210 from $204 and keeps an Outperform rating on the shares as part of the firm's Top 10 Themes for 2026 note on the Banks, Brokers, and Alternative Managers. Heading into 2026, the firm notes Retail Brokers and Alts are its favorite subsectors.
Barclays
Overweight
maintain
$218
2025-12-24
Reason
Barclays
Price Target
$218
2025-12-24
maintain
Overweight
Reason
Barclays keeps an Overweight rating on Ares Management with a $218 price target after the Financial Times reported the company is considering acquiring a private equity firm. A hypothetical deal could be modestly dilutive, but could also have more long-term strategic importance, the analyst tells investors in a research note.
About ARES
Ares Management Corporation is an alternative investment manager offering clients complementary primary and secondary investment solutions across various asset classes. Its segments include Credit Group, Private Equity Group, Real Assets Group, Secondaries Group, and Other. The Credit Group segment manages credit strategies across the liquid and illiquid spectrum, including liquid credit, alternative credit, direct lending and APAC credit. The Private Equity Group segment categorizes its investment strategies as corporate private equity, special opportunities and APAC private equity. The Real Assets Group segment manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group segment invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit. It has operations across North America, South America, Europe, Asia Pacific and the Middle East.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
